Pyridazinone derivatives
Pyridazinone derivatives represented by the formula (I) and antiplatelet agents containing them: (I) [wherein R is a hydrogen atom or a C1-C4 alkyl group, X is a hydrogen atom, a chlorine atom or a bromine atom, Ar is a pyridyl group or a phenyl group substituted with OR1 (wherein R1 is a hydrogen a...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English |
Published |
05.01.1999
|
Edition | 6 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Pyridazinone derivatives represented by the formula (I) and antiplatelet agents containing them: (I) [wherein R is a hydrogen atom or a C1-C4 alkyl group, X is a hydrogen atom, a chlorine atom or a bromine atom, Ar is a pyridyl group or a phenyl group substituted with OR1 (wherein R1 is a hydrogen atom or a C1-C4 alkyl group) and A {wherein A is a hydrogen atom, a halogen atom, a C1-C4 alkyl group or OR2 (wherein R2 is a hydrogen atom or a C1-C4 alkyl group)}, Y is C1-C8 alkylene wherein one carbon atom on the straight chain is substituted with one OR1 group (wherein R1 is the same as defined above), and Z1 and Z2 are independently a hydrogen atom, a halogen atom, a C1-C4 alkyl group or a OR1 group (wherein R1 is the same as defined above)]. These compounds have strong antiplatelet effects, are excellently safe, and can be used as active ingredients of prophylactic and therapeutic drugs for various thrombotic diseases.
Pyridazinone derivatives represented by the formula (I) and antiplatelet agents containing them: (I) [wherein R is a hydrogen atom or a C1-C4 alkyl group, X is a hydrogen atom, a chlorine atom or a bromine atom, Ar is a pyridyl group or a phenyl group substituted with OR1 (wherein R1 is a hydrogen atom or a C1-C4 alkyl group) and A {wherein A is a hydrogen atom, a halogen atom, a C1-C4 alkyl group or OR2 (wherein R2 is a hydrogen atom or a C1-C4 alkyl group)}, Y is C1-C8 alkylene wherein one carbon atom on the straight chain is substituted with one OR1 group (wherein R1 is the same as defined above), and Z1 and Z2 are independently a hydrogen atom, a halogen atom, a C1-C4 alkyl group or a OR1 group (wherein R1 is the same as defined above)]. These compounds have strong antiplatelet effects, are excellently safe, and can be used as active ingredients of prophylactic and therapeutic drugs for various thrombotic diseases. |
---|---|
Bibliography: | Application Number: US19970936600 |